NewGenIvf Group Limited Warrants
NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company's fertility treatment solutions include in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sp… Read more
Market Cap & Net Worth: NewGenIvf Group Limited Warrants (NIVFW)
NewGenIvf Group Limited Warrants (NASDAQ:NIVFW) has a market capitalization of $147.30 ($147.30) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #47068 globally and #14603 in its home market, demonstrating a -0.61% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying NewGenIvf Group Limited Warrants's stock price $0.02 by its total outstanding shares 9037 (9.04K).
NewGenIvf Group Limited Warrants Market Cap History: 2024 to 2026
NewGenIvf Group Limited Warrants's market capitalization history from 2024 to 2026. Data shows growth from $230.44 to $147.30 (0.00% CAGR).
NewGenIvf Group Limited Warrants Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how NewGenIvf Group Limited Warrants's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
NewGenIvf Group Limited Warrants's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $230.44 | $5.43 Million | -$525.00K | 0.00x | N/A |
Competitor Companies of NIVFW by Market Capitalization
Companies near NewGenIvf Group Limited Warrants in the global market cap rankings as of March 18, 2026.
Key companies related to NewGenIvf Group Limited Warrants by market ranking:
- Sambu Construction Co. Ltd. (KQ:001470): Ranked #47059 globally with a market cap of $2.35K USD ( ₩3.44 Million KRW).
- VINCO FINANCIAL GRP (BE:4QH): Ranked #47060 globally with a market cap of $2.35K USD ( €2.29K EUR).
- CHAMPION REAL EST. UTS (F:Q9S): Ranked #47069 globally with a market cap of $2.34K USD ( €2.28K EUR).
- GUANGSHEN RAIL-H- (MU:GRCH): Ranked #47070 globally with a market cap of $2.34K USD ( €2.28K EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #47059 | Sambu Construction Co. Ltd. | KQ:001470 | $2.35K | ₩347.00 |
| #47060 | VINCO FINANCIAL GRP | BE:4QH | $2.35K | €0.23 |
| #47069 | CHAMPION REAL EST. UTS | F:Q9S | $2.34K | €0.23 |
| #47070 | GUANGSHEN RAIL-H- | MU:GRCH | $2.34K | €0.25 |
NewGenIvf Group Limited Warrants Historical Marketcap From 2024 to 2026
Between 2024 and today, NewGenIvf Group Limited Warrants's market cap moved from $230.44 to $ 147.30, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $147.30 | -4.12% |
| 2025 | $153.63 | -33.33% |
| 2024 | $230.44 | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of NewGenIvf Group Limited Warrants was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $147.30 USD |
| MoneyControl | $147.30 USD |
| MarketWatch | $147.30 USD |
| marketcap.company | $147.30 USD |
| Reuters | $147.30 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.